Cyclo Therapeutics, Inc.

CYTHNASDAQHealthcare

$0.72

+$0.00(+0.00%)

Market Cap$23589778

P/E Ratio—

52W High$1.6199

52W Low$0.55

Avg Volume1.9M

Open$0.72

Beta-0.57

Overview

Cyclo Therapeutics, Inc. (CYTH) Insider Trading

Form 4 buy vs sell counts, ratio, and sentiment — switch this quarter or last 12 months; chart and transactions below.

SEC EDGAR · FMP · CYTH · as of Jun 9, 2026

Activity summary

Buy transactions

P-Purchase only

Sell transactions

12 Months

Buy/Sell ratio

0.00

Buy/Sell (by trades)

Overall sentiment

NEUTRAL

↑ Buy 0%Active transactions only · RSU vesting excluded100% Sell ↓

Cyclo Therapeutics, Inc. insiders have shown mixed buying and selling activity over the past 12 Months.

▸ Source: SEC EDGAR · Form 3 & 4 · via Financial Modeling Prep · Buy = P-Purchase only · Sell = S-Sale only

As of Jun 9, 2026

CYTH insider buying and selling by quarter

CYTH insider selling · CYTH insider buying stocks · quarterly insider activity

Total insider buying (incl. awards)Total insider selling

8.1M4.0M0

2023 Q2

2023 Q3

2023 Q4

2024 Q1

2024 Q2

2024 Q3

2024 Q4

2025 Q1

Mobile shows last 4Q · Desktop shows full 8Q

▸ Source: SEC EDGAR · Form 3 & 4 · via Financial Modeling Prep · last 8 quarters

As of Jun 9, 2026

Recent insider transactions

CYTH executive sell shares · CYTH board member insider trading · CYTH insider trading SEC filing

Showing 66 most recent · Common Stock · Form 4 only

Scroll horizontally to see all columns

Date	Insider	Type	Shares	Price	Value	After trans.	Filing
Feb 27, 2025	CONKLING WILLIAM Director	Award	27,654	—	—	77,884	Form 4
Feb 27, 2025	Wong Vivien Director	Award	25,140	—	—	64,853	Form 4
Feb 27, 2025	Cross Shawn Director	Award	28,597	—	—	136,346	Form 4
Feb 27, 2025	Toig Randall M. Director	Award	33,311	—	—	179,137	Form 4
Feb 27, 2025	STRATTAN CE RICK Director	Award	30,169	—	—	399,272	Form 4
Feb 27, 2025	Ostronic Francis Patrick Director	Award	70,329	—	—	419,100	Form 4
Feb 27, 2025	Sieger Markus Director	Award	58,138	—	—	440,260	Form 4
Feb 27, 2025	SHANAHAN WILLIAM S Director	Award	25,140	—	—	173,966	Form 4
Dec 23, 2024	Rafael Holdings, Inc. 10 percent owner	Other	3,968,254	$0.63	$2.50M⚡	12,998,194	Form 4
Nov 15, 2024	CONKLING WILLIAM Director	Award	16,660	—	—	50,230	Form 4
Nov 15, 2024	Cross Shawn Director	Award	17,228	—	—	107,749	Form 4
Nov 15, 2024	SHANAHAN WILLIAM S Director	Award	15,145	—	—	148,826	Form 4
Nov 15, 2024	Sieger Markus Director	Award	35,022	—	—	382,122	Form 4
Nov 15, 2024	STRATTAN CE RICK Director	Award	63,608	—	—	369,103	Form 4
Nov 15, 2024	Toig Randall M. Director	Award	20,067	—	—	145,826	Form 4
Nov 15, 2024	Wong Vivien Director	Award	15,145	—	—	39,713	Form 4
Aug 16, 2024	SHANAHAN WILLIAM S Director	Award	7,937	—	—	133,681	Form 4
Aug 16, 2024	CONKLING WILLIAM Director	Award	8,731	—	—	33,570	Form 4
Aug 16, 2024	Wong Vivien Director	Award	7,937	—	—	24,568	Form 4
Aug 16, 2024	Cross Shawn Director	Award	9,028	—	—	90,521	Form 4
Aug 16, 2024	Toig Randall M. Director	Award	10,516	—	—	125,759	Form 4
Aug 16, 2024	STRATTAN CE RICK Director	Award	9,524	—	—	305,495	Form 4
Aug 16, 2024	Sieger Markus Director	Award	18,354	—	—	347,100	Form 4
Jun 3, 2024	SHANAHAN WILLIAM S Director	Award	7,813	—	—	125,744	Form 4
Jun 3, 2024	Sieger Markus Director	Award	18,067	—	—	328,746	Form 4

CONKLING WILLIAM

Director

Award

Date

Feb 27

27,654

Price

—

Value

—

View Form 4 on SEC.gov

Wong Vivien

Director

Award

Date

Feb 27

25,140

Price

—

Value

—

View Form 4 on SEC.gov

Cross Shawn

Director

Award

Date

Feb 27

28,597

Price

—

Value

—

View Form 4 on SEC.gov

Toig Randall M.

Director

Award

Date

Feb 27

33,311

Price

—

Value

—

View Form 4 on SEC.gov

STRATTAN CE RICK

Director

Award

Date

Feb 27

30,169

Price

—

Value

—

View Form 4 on SEC.gov

Ostronic Francis Patrick

Director

Award

Date

Feb 27

70,329

Price

—

Value

—

View Form 4 on SEC.gov

Sieger Markus

Director

Award

Date

Feb 27

58,138

Price

—

Value

—

View Form 4 on SEC.gov

SHANAHAN WILLIAM S

Director

Award

Date

Feb 27

25,140

Price

—

Value

—

View Form 4 on SEC.gov

Rafael Holdings, Inc.

10 percent owner

Other

Date

Dec 23

3,968,254

Price

$0.63

Value

$2.50M ⚡

View Form 4 on SEC.gov

CONKLING WILLIAM

Director

Award

Date

Nov 15

16,660

Price

—

Value

—

View Form 4 on SEC.gov

Cross Shawn

Director

Award

Date

Nov 15

17,228

Price

—

Value

—

View Form 4 on SEC.gov

SHANAHAN WILLIAM S

Director

Award

Date

Nov 15

15,145

Price

—

Value

—

View Form 4 on SEC.gov

Sieger Markus

Director

Award

Date

Nov 15

35,022

Price

—

Value

—

View Form 4 on SEC.gov

STRATTAN CE RICK

Director

Award

Date

Nov 15

63,608

Price

—

Value

—

View Form 4 on SEC.gov

Toig Randall M.

Director

Award

Date

Nov 15

20,067

Price

—

Value

—

View Form 4 on SEC.gov

Wong Vivien

Director

Award

Date

Nov 15

15,145

Price

—

Value

—

View Form 4 on SEC.gov

SHANAHAN WILLIAM S

Director

Award

Date

Aug 16

7,937

Price

—

Value

—

View Form 4 on SEC.gov

CONKLING WILLIAM

Director

Award

Date

Aug 16

8,731

Price

—

Value

—

View Form 4 on SEC.gov

Wong Vivien

Director

Award

Date

Aug 16

7,937

Price

—

Value

—

View Form 4 on SEC.gov

Cross Shawn

Director

Award

Date

Aug 16

9,028

Price

—

Value

—

View Form 4 on SEC.gov

Toig Randall M.

Director

Award

Date

Aug 16

10,516

Price

—

Value

—

View Form 4 on SEC.gov

STRATTAN CE RICK

Director

Award

Date

Aug 16

9,524

Price

—

Value

—

View Form 4 on SEC.gov

Sieger Markus

Director

Award

Date

Aug 16

18,354

Price

—

Value

—

View Form 4 on SEC.gov

SHANAHAN WILLIAM S

Director

Award

Date

Jun 3

7,813

Price

—

Value

—

View Form 4 on SEC.gov

Sieger Markus

Director

Award

Date

Jun 3

18,067

Price

—

Value

—

View Form 4 on SEC.gov

⚡ = value ≥ $1M · Award/Option price shows — · formType=4 · securityName=Common Stock · url → sec.gov/Archives/edgar

1 / 3

▸ Source: SEC EDGAR · Form 4 filings · ⚡ = value ≥ $1M · Award/Option price shows —

About CYTH insider trading

CYTH insider trades

Cyclo Therapeutics, Inc. (CYTH) insider trading data is sourced from SEC Form 4 filings submitted by corporate insiders, including CYTH. Over the past 12 months, 0 insiders have filed transactions with the SEC. CYTH insiders have been mixed buying and selling, which may reflect pre-scheduled Rule 10b5-1 plan executions.

For Cyclo Therapeutics, Inc.'s institutional ownership breakdown and insider ownership percentage, see the Ownership tab → Ownership tab →

Buy/Sell signal logic

acquisitionOrDisposition field:

A = Acquisition (buy) · D = Disposition (sell)

RSU vesting (M-Exempt) excluded from sentiment

Form 4SEC filing required within 2 business days of any insider transaction

10b5-1Pre-scheduled trading plan that allows insiders to sell on autopilot

Open MktDirect purchase or sale on the open market (excludes awards, options)

Ownership SEC filings Financial statements Price history Forecast & ratings Earnings

Frequently asked questions

CYTH insider trading · 5 questions

The insiders of Cyclo Therapeutics, Inc. (CYTH) include executives and directors such as CYTH, among others. Over the past 12 months, 0 insiders have filed Form 4 transactions with the SEC. Insider transactions are required to be reported within 2 business days of the trade date.

CYTH board member insider tradingwho are CYTH insidersCYTH insider rosterCyclo Therapeutics, Inc. executives insider activity

▸ Source: FMP /stable/insider-trading/search · SEC EDGAR Form 3 & 4 · acquisitionOrDisposition A=Buy, D=Sell · RSU vesting (M-Exempt) excluded from sentiment bar · As of Jun 9, 2026